Nathalie Ledee | Medicine and Health Sciences | Innovative Research Award

Published on by Top Teachers

Innovative Research Award

Nathalie Lédée
MatriceLAB Innove, France

Nathalie Lédée
Affiliation MatriceLAB Innove
Country France
Scopus ID 6603321197
Documents 94
Citations 3,407
h-index 33
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-3166-2643

Nathalie Lédée, M.D., Ph.D., affiliated with MatriceLAB Innove, France, is a physician-scientist whose work has contributed to the advancement of reproductive medicine, reproductive immunology, embryo implantation biology, and assisted reproductive technologies (ART). Her academic and professional career combines clinical leadership, translational research, biotechnology innovation, and scientific mentorship. She has served in senior research and healthcare leadership positions while maintaining an active publication record and developing patented technologies aimed at improving implantation success and fertility outcomes.[1][2]

Abstract

This article summarizes the academic, clinical, and scientific achievements of Nathalie Lédée, a French physician-scientist specializing in reproductive medicine and reproductive immunology. Her research has focused on understanding immune tolerance, cytokine regulation, embryo implantation mechanisms, and biomarker-guided fertility treatments. Through leadership roles in academia, healthcare institutions, and biotechnology innovation, she has contributed to translational approaches that connect laboratory discoveries with clinical reproductive care. Her scientific output, patents, and international collaborations have influenced contemporary research in embryo implantation and assisted reproduction.[1][3]

Keywords

Reproductive Medicine; Reproductive Immunology; Embryo Implantation; Assisted Reproductive Technology; IVF; Cytokines; Fertility Research; Translational Medicine; Biomarkers; Endometrial Immune Profiling; Clinical Research; Human Reproduction.

Introduction

Nathalie Lédée obtained her Doctor of Medicine degree from the University Paris VI in 1993, completed a Master of Science at McGill University in Canada in 1995, and earned a Ph.D. in reproductive immunology in 2003. Her academic development was complemented by clinical training in obstetrics, gynecology, and reproductive medicine. Throughout her career she has pursued the integration of fundamental immunological discoveries into practical fertility treatments and patient-centered reproductive care.[1]

Her professional activities have included appointments as assistant professor, senior investigator at INSERM research units, invited professor at the University of Liège, head of reproductive medicine centers, and president of MatriceLab Innove. These positions enabled her to contribute to multidisciplinary initiatives linking clinical medicine, biotechnology innovation, and translational research.[2]

Research Profile

Nathalie Lédée’s research centers on the immunological events occurring during embryo implantation and early pregnancy. Her investigations have examined maternal-fetal dialogue, cytokine regulation, immune tolerance, uterine receptivity, and biomarkers associated with reproductive success. She has emphasized translational methodologies designed to improve embryo selection, implantation outcomes, and personalized reproductive therapies.[3]

  • Reproductive Medicine and Fertility Care
  • Reproductive Immunology
  • Embryo Implantation Biology
  • Assisted Reproductive Technologies (ART)
  • Endometrial Immune Profiling
  • Biomarker Discovery and Validation
  • Cytokine Biology
  • Translational Clinical Research

Research Contributions

Among her recognized scientific contributions is the development of immune-based approaches for evaluating uterine receptivity and implantation potential. Her work has advanced understanding of how cytokine balance and local immune regulation influence successful embryo implantation and pregnancy outcomes.[3]

She is also inventor of patented technologies addressing embryo implantation and oocyte selection. These innovations seek to improve clinical decision-making within IVF and ART programs by introducing objective biological markers into reproductive treatment pathways.[4]

  • Patent PCT WO-2008/009705 involving granulocyte colony-stimulating factor (G-CSF) assessment in follicular fluid.
  • Patent PCT/EP2013/065355 concerning methods for increasing implantation success in assisted reproduction.
  • Leadership of translational fertility research programs connecting laboratory findings to patient care.
  • Contributions to European and international reproductive medicine networks.

Publications

Nathalie Lédée has authored influential studies in reproductive immunology and embryo implantation, including randomized trials on endometrial immune profiling and precision therapy that improved live birth outcomes after embryo transfer.[3] Her work further explored uterine immune profiling in assisted reproductive technology, advancing personalized fertility care.[4] Additional contributions include research on sperm microRNA expression and fertility biomarkers,[5] immune predictors of recurrent miscarriage and therapeutic outcomes,[6] and the role of interleukin-18 in predicting embryo transfer success.[7]

Research Impact

The research record of Nathalie Lédée includes 94 indexed documents, more than 3,407 citations, and an h-index of 33. These indicators reflect sustained scholarly engagement within reproductive medicine and reproductive immunology. Her publications have addressed clinically relevant challenges including implantation failure, recurrent miscarriage, immune biomarkers, and fertility treatment optimization.[1]

Her contributions have been recognized through competitive grants, scientific awards, international fellowships, leadership positions in European research initiatives, and memberships in major professional societies including ESHRE, the American Society of Reproductive Immunology, and European reproductive medicine organizations.[2]

Award Suitability

The nomination of Nathalie Lédée for the Innovative Research Award may be considered on the basis of her long-standing contributions to reproductive medicine, translational immunology, fertility innovation, and clinical leadership. Her work demonstrates a sustained commitment to developing evidence-based approaches that improve reproductive outcomes and expand scientific understanding of embryo implantation biology.[3][4]

Additional factors supporting recognition include internationally patented inventions, leadership in fertility centers, successful integration of biotechnology innovation into healthcare practice, and publication of influential research addressing major challenges in assisted reproduction.[4][5]

Conclusion

Nathalie Lédée has established a distinguished career at the intersection of clinical reproductive medicine, reproductive immunology, and translational biomedical innovation. Through academic research, leadership of fertility programs, biotechnology entrepreneurship, and development of novel diagnostic and therapeutic strategies, she has contributed to advancements in understanding and improving human reproduction. Her body of work represents a notable example of translational science applied to reproductive healthcare.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Nathalie Lédée, Author ID 6603321197. Scopus. https://www.scopus.com/authid/detail.uri?authorId=6603321197
  2. ORCID. (n.d.). Nathalie Lédée – ORCID Research Profile. https://orcid.org/0000-0002-3166-2643
  3. Lédée, N., Petitbarat, M., Dray, G., Chevrier, L., Kazhalawi, A., Rahmati, M., et al. (2025). Endometrial immune profiling and precision therapy increase live birth rate after embryo transfer: a randomised controlled trial. Frontiers in Immunology. DOI: https://doi.org/10.3389/fimmu.2025.1523871
  4. Lédée, N., Petitbarat, M., Prat-Ellenberg, L., Dray, G., Vaucoret, V., Kazhalawi, A., et al. (2023). The Next Frontier in ART: Harnessing the Uterine Immune Profile for Improved Performance. International Journal of Molecular Sciences. https://www.mdpi.com/1422-0067/24/14/11322
  5. Cassuto, N.G., Lédée, N., Boitrelle, F., Mouik, H., Larue, L., Keromnes, G., et al. (2025). Genome-Wide microRNA Expression Profiling in Human Spermatozoa and Its Relation to Sperm Quality. Genes. https://www.mdpi.com/2073-4425/16/1/53
  6. Kolanska, K., Lédée, N., Dabi, Y., Dechartres, A., et al. (2021). Unexplained recurrent miscarriages: predictive value of immune biomarkers and immunomodulatory therapies for live birth. American Journal of Reproductive Immunology. https://onlinelibrary.wiley.com/doi/abs/10.1111/aji.13425
  7. Ledee-Bataille, N., Olivennes, F., Kadoch, J., Dubanchet, S., Frydman, N., Chaouat, G., & Frydman, R. Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer. Human Reproduction. DOI: https://doi.org/10.1093/humrep/deh356

Saksham Kohli | Health Professions | Best Researcher Award

Published on by Top Teachers

Best Researcher Award

Saksham Kohli
Cook County Health

Saksham Kohli
Affiliation Cook County Health
Country United States
Scopus ID 59495632900
Documents 52
Citations 4
Subject Area Health Professions
Event Top Teachers Awards
ORCID 0000-0001-6983-1804

The Best Researcher Award recognition highlights the scholarly activities and emerging research contributions of Saksham Kohli at Cook County Health. Working within the field of Health Professions, Saksham Kohli has contributed to studies involving gastroenterology, hepatology, nephrology, and healthcare outcomes research. Recent publications demonstrate engagement with evidence-based clinical investigations addressing inpatient outcomes, quality improvement methodologies, readmission patterns, and patient survival analyses.[1] Through interdisciplinary research and participation in contemporary clinical studies, Saksham Kohli has supported the advancement of knowledge relevant to healthcare quality, patient management, and population-level medical outcomes.[2]

Abstract

This article presents an academic overview of Saksham Kohli and the research profile associated with recognition under the Best Researcher Award category. The researcher’s recent scholarly output focuses on clinical outcomes, gastrointestinal diseases, healthcare quality assessment, and patient-centered investigations. Published studies have addressed metabolic dysfunction-associated liver disease, endoscopy performance evaluation, alcoholic hepatitis readmissions, and survival considerations among elderly dialysis patients.[2]

Keywords

Health Professions, Gastroenterology, Clinical Outcomes Research, Healthcare Quality Improvement, Hepatology, Readmission Studies, Evidence-Based Medicine.

Introduction

Healthcare research plays a significant role in improving clinical practice, patient outcomes, and healthcare system efficiency. Researchers working across medical specialties contribute to evidence generation that supports informed decision-making and policy development. Saksham Kohli’s published work reflects participation in studies examining disease burden, treatment outcomes, healthcare utilization, and quality improvement initiatives within contemporary clinical settings.[3]

Research Profile

Affiliated with Cook County Health in the United States, Saksham Kohli has developed a research profile centered on applied clinical investigations. Indexed under Scopus Author ID 59495632900, the researcher has contributed to publications spanning gastroenterology, hepatology, nephrology, and healthcare analytics. These studies demonstrate engagement with real-world healthcare datasets and outcome-oriented medical research.[1]

Research Contributions

The research contributions of Saksham Kohli include analyses of metabolic-dysfunction-associated steatotic liver disease and its impact on inpatient outcomes, assessments of endoscope tip angulation performance, nationwide evaluations of alcoholic hepatitis readmissions, and investigations involving elderly dialysis populations.[2] These studies contribute to clinical understanding by examining patient outcomes, healthcare quality metrics, and disease management strategies using quantitative methodologies.[4]

Publications

  • Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes.
  • Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
  • Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
  • Octogenarians on Dialysis; Navigating Survival Amidst Struggles.

Research Impact

The available publication record demonstrates contributions to clinically relevant topics affecting patient care and healthcare delivery. Research addressing liver disease outcomes, readmission risk factors, endoscopic performance, and nephrology-related survival outcomes provides useful evidence for healthcare professionals and researchers seeking to improve treatment effectiveness and quality standards.[5]

Award Suitability

Saksham Kohli’s profile aligns with the objectives of the Best Researcher Award through demonstrated scholarly engagement, publication activity, and contributions to healthcare research. The combination of outcome-based studies, quality improvement initiatives, and multidisciplinary clinical investigations reflects an active commitment to advancing medical knowledge and evidence-based practice.[1]

Conclusion

Saksham Kohli has contributed to a growing body of healthcare research through studies addressing important clinical and quality-of-care challenges. The published work demonstrates involvement in contemporary medical investigations and supports the dissemination of evidence relevant to patient outcomes, healthcare systems, and disease management. These accomplishments provide a foundation for recognition within academic and professional research communities.

References

  1. Elsevier. (n.d.). Scopus author details: Saksham Kohli, Author ID 59495632900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59495632900
  2. Kohli, S. et al. (2026). Impact of MASLD and MASH on Clostridioides difficile Inpatient Outcomes.
    https://doi.org/10.3390/gastroent17020038
  3. Kohli, S. et al. (2026). Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
    https://doi.org/10.1055/a-2877-9452
  4. Kohli, S. et al. (2026). Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
    https://doi.org/10.3390/gidisord8020027
  5. Kohli, S. et al. (2025). Octogenarians on Dialysis; Navigating Survival Amidst Struggles.
    https://doi.org/10.34172/jnp.2024.21476
  6. Top Teachers Awards. (n.d.). Best Researcher Award Recognition Program.
    topteachers.net